Company page

Alligator Bioscience Ab

Alligator Bioscience Ab, trading under the ticker ATORX, is a publicly listed company on the Swedish market. With a market capitalization of approximately 2.75 million, the company focuses on developing innovative immuno-oncology therapies. Alligator Bioscience is dedicated to advancing treatments that target cancer through its proprietary technology platforms.

ATORX:OMXSTOUpdated August 29, 2026
Alligator Bioscience Ab logo
Ticker
ATORX:OMXSTO
Asset type
Stock
Market cap
$1.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXSTO
Currency
SEK